We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Scientists Work on Sequencing of Cattle Genome

By Biotechdaily staff writers
Posted on 22 May 2002
An international consortium of French, Canadian, and US scientists have begun work on a sequence-ready map that will enable them to quickly and efficiently sequence the entire cattle genome.

The scientists will create a sequence-ready bacterial artificial chromosome (BAC) map and anchor it to the humane genome map by reference points called comparatively-anchored sequence tagged sites, or CASTS. More...
Constructing the map will proceed in three phases. First, all 280,000 clones of a BAC library produced by a laboratory at the Children's Hospital Oakland Research Institute (CHOR, CA, USA) will be fingerprinted by a group at the British Columbia Cancer Agency (BCCA, Canada). Second, sequencing of the ends of at least 100,000 fingerprinted BAC-clones will be done by a team at the University of Illinois (Champaign, USA) and The Institute for Genomic Research (TIGRE, Rockville, MD, USA).

The sequence-ready BAC map will be created by merging the BAC fingerprints with the BAC-end sequence data. The entire array of cattle BAC clones, called contigs, will be scaffolded on to specific cattle chromosomes using a bioinformatics tool called COMPASS. The assignment of contigs to cattle chromosomes will be based on a whole-genome cattle-human comparative gene map. Reciprocal exchange of BAC fingerprinted and end-sequenced clones with other scientists will be used to create a thorough sequence-ready map.

To date, more than 125,000 cattle BAC clones have been fingerprinted and more than 2,000 BAC end-sequences have been produced. Once this stage is completed, a new consortium will produce a draft sequence of the entire cattle genome. This sequencing will help scientists understand the evolution of mammalian genomes and provide powerful new tools for animal breeding and securing the safety of the world's supply of meat and milk.

"Already, the research has shown that sequenced cattle DNA can be more valuable than sequenced mouse or rate genomic DNA is predicting the locations of evolutionarily conserved noncoding gene regulatory elements,” said Harris Lewin, a professor of animal sciences at the University of Illinois who is helping to coordinate the project.




Related Links:
University of Illinois
TIGRE

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.